A POST-HOC ANALYSIS OF POTENTIAL ETHNIC DIFFERENCES IN LORLATINIB PHARMACOKINETICS (PK) IN PATIENTS WITH ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC).

J. Albanez,Y. Pithavala,J. Chen

CLINICAL PHARMACOLOGY & THERAPEUTICS(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要